SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-20-236386
Filing Date
2020-08-31
Accepted
2020-08-31 17:17:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC14D9C d74080dsc14d9c.htm SC14D9C 11967
2 EX-99.1 d74080dex991.htm EX-99.1 22971
3 EX-99.2 d74080dex992.htm EX-99.2 10512
4 EX-99.3 d74080dex993.htm EX-99.3 6378
  Complete submission text file 0001193125-20-236386.txt   53407
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filed by) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Subject) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-90051 | Film No.: 201152542
SIC: 2834 Pharmaceutical Preparations